These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34207556)

  • 21. Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.
    Aurisicchio L; Salvatori E; Lione L; Bandini S; Pallocca M; Maggio R; Fanciulli M; De Nicola F; Goeman F; Ciliberto G; Conforti A; Luberto L; Palombo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):78. PubMed ID: 30764846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy.
    Łuksza M; Riaz N; Makarov V; Balachandran VP; Hellmann MD; Solovyov A; Rizvi NA; Merghoub T; Levine AJ; Chan TA; Wolchok JD; Greenbaum BD
    Nature; 2017 Nov; 551(7681):517-520. PubMed ID: 29132144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC).
    Chen H; Yang G; Xiao J; Zheng L; You L; Zhang T
    Cancer Lett; 2020 Oct; 490():12-19. PubMed ID: 32590021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Identification of neoantigens and development of antigen-specific immunotherapy].
    Shinohara S; Takahashi Y; Demachi-Okamura A; Matsushita H
    Rinsho Ketsueki; 2020; 61(9):1433-1439. PubMed ID: 33162546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer.
    Martin SD; Wick DA; Nielsen JS; Little N; Holt RA; Nelson BH
    Oncoimmunology; 2017; 7(1):e1371895. PubMed ID: 29296522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.
    Ye L; Creaney J; Redwood A; Robinson B
    J Thorac Oncol; 2021 Jun; 16(6):922-932. PubMed ID: 33581342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
    Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA
    Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
    Zhang X; Qi Y; Zhang Q; Liu W
    Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning.
    Shi Y; Guo Z; Su X; Meng L; Zhang M; Sun J; Wu C; Zheng M; Shang X; Zou X; Cheng W; Yu Y; Cai Y; Zhang C; Cai W; Da LT; He G; Han ZG
    Bioinformatics; 2020 Dec; 36(19):4894-4901. PubMed ID: 32592462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.
    Qin Y; Ekmekcioglu S; Forget MA; Szekvolgyi L; Hwu P; Grimm EA; Jazaeri AA; Roszik J
    Front Immunol; 2017; 8():689. PubMed ID: 28670312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy.
    Blaeschke F; Paul MC; Schuhmann MU; Rabsteyn A; Schroeder C; Casadei N; Matthes J; Mohr C; Lotfi R; Wagner B; Kaeuferle T; Feucht J; Willier S; Handgretinger R; StevanoviĆ S; Lang P; Feuchtinger T
    Cytotherapy; 2019 Sep; 21(9):973-986. PubMed ID: 31351799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.
    Ren L; Leisegang M; Deng B; Matsuda T; Kiyotani K; Kato T; Harada M; Park JH; Saloura V; Seiwert T; Vokes E; Agrawal N; Nakamura Y
    Oncoimmunology; 2019; 8(4):e1568813. PubMed ID: 30906664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
    Chae YK; Anker JF; Oh MS; Bais P; Namburi S; Agte S; Giles FJ; Chuang JH
    Sci Rep; 2019 Mar; 9(1):3235. PubMed ID: 30824826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
    Matsushita H; Hasegawa K; Oda K; Yamamoto S; Nishijima A; Imai Y; Asada K; Ikeda Y; Karasaki T; Fujiwara K; Aburatani H; Kakimi K
    Oncoimmunology; 2017; 6(8):e1338996. PubMed ID: 28920005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of neoantigens derived from alternative splicing and RNA modification.
    Park J; Chung YJ
    Genomics Inform; 2019 Sep; 17(3):e23. PubMed ID: 31610619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor neoantigens: from basic research to clinical applications.
    Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C
    J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.
    Kalaora S; Wolf Y; Feferman T; Barnea E; Greenstein E; Reshef D; Tirosh I; Reuben A; Patkar S; Levy R; Quinkhardt J; Omokoko T; Qutob N; Golani O; Zhang J; Mao X; Song X; Bernatchez C; Haymaker C; Forget MA; Creasy C; Greenberg P; Carter BW; Cooper ZA; Rosenberg SA; Lotem M; Sahin U; Shakhar G; Ruppin E; Wargo JA; Friedman N; Admon A; Samuels Y
    Cancer Discov; 2018 Nov; 8(11):1366-1375. PubMed ID: 30209080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A liposomal RNA vaccine inducing neoantigen-specific CD4
    Salomon N; Vascotto F; Selmi A; Vormehr M; Quinkhardt J; Bukur T; Schrörs B; Löewer M; Diken M; Türeci Ö; Sahin U; Kreiter S
    Oncoimmunology; 2020 Jun; 9(1):1771925. PubMed ID: 32923128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.